[Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma].

F Boxberger, K Happich, I Schirner, W M Brueckl (Co-author), W Hohenberger, E G Hahn, A Wein

    Research output: Contribution to journalCase reportpeer-review

    5 Citations (Web of Science)
    Original languageGerman
    Pages (from-to)881-884
    JournalZEITSCHRIFT FUR GASTROENTEROLOGIE
    Volume40
    Issue number10
    DOIs
    Publication statusPublished - 2002

    Keywords

    • CANCER
    • COMBINATION
    • SURVIVAL
    • TRIAL

    Cite this